On ECHEMI
Home > Drugs > Lianyungang Runzhong Pharmaceutical Co., Ltd.
Lianyungang Runzhong Pharmaceutical Co., Ltd.
  • Founded in:

    2010-10-20
  • Country:

    China China
  • Address:

    No. 16, Jinqiao Road, Dapu Industrial Zone, Lianyungang Economic and Technological Development Zone
  • Tax NO.:

    913207005629851634
  • Registered Funds:

    103.528805 yuan
  • Email:

Related Drugs
Decitabine
Name Description Content CAS NO. Registered Holders
5-Aza-2'-deoxycytidine

Extract from the above information

More

Extract from the above information

2353-33-5 28
Lactitol
Name Description Content CAS NO. Registered Holders
LACTITOL

Extract from the above information

More

Extract from the above information

585-86-4 2
Magnesium Isoglycyrrhizinate
Name Description Content CAS NO. Registered Holders
Magnesium Isoglycyrrhizinate

Extract from the above information

More

Extract from the above information

658701-67-8 5
Azelnidipine
C33H34N4O6
Name Description Content CAS NO. Registered Holders
Azelnidipine

Azelnidipine is a new type of dihydropyridine calcium channel blocker. It has characteristics that general calcium antagonists do not have. It can slow down the heart rate and has a high affinity with vascular tissue. Because of its mild action, it rarely causes reflex tachycardia. After long-term use of azelnidipine, the heart rate and PRA tend to decrease compared with the control group. Due to its high lipid solubility, it is mainly distributed in vascular tissue. Therefore, in many animal models, azelnidipine also shows good anti-atherosclerotic and kidney and heart protective effects. Therefore, azelnidipine can also be used to treat atherosclerosis.

More

Azelnidipine is a new type of dihydropyridine calcium channel blocker. It has characteristics that general calcium antagonists do not have. It can slow down the heart rate and has a high affinity with vascular tissue. Because of its mild action, it rarely causes reflex tachycardia. After long-term use of azelnidipine, the heart rate and PRA tend to decrease compared with the control group. Due to its high lipid solubility, it is mainly distributed in vascular tissue. Therefore, in many animal models, azelnidipine also shows good anti-atherosclerotic and kidney and heart protective effects. Therefore, azelnidipine can also be used to treat atherosclerosis.

123524-52-7 9
Fluticasone Propionate
Name Description Content CAS NO. Registered Holders
Fluticasone propionate

80474-14-2 41
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.